KBC Group NV - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
KBC Group NV ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2016$9,000
-93.6%
656
-89.0%
0.00%
-100.0%
Q3 2016$141,000
+370.0%
5,938
+477.1%
0.00%
Q2 2016$30,000
-79.5%
1,029
-77.4%
0.00%
-100.0%
Q1 2016$146,000
-77.6%
4,549
-70.2%
0.00%
-83.3%
Q4 2015$652,000
-45.1%
15,241
-54.8%
0.01%
-50.0%
Q3 2015$1,187,000
-57.9%
33,716
-45.1%
0.02%
-33.3%
Q2 2015$2,820,000
+56.3%
61,422
+59.6%
0.04%
+56.5%
Q1 2015$1,804,000
-29.4%
38,488
-52.3%
0.02%
-23.3%
Q4 2014$2,556,000
+96.8%
80,667
+47.2%
0.03%
-33.3%
Q3 2014$1,299,000
-26.8%
54,788
-7.4%
0.04%
+125.0%
Q2 2014$1,775,00059,1920.02%
Other shareholders
IMPAX LABORATORIES INC shareholders Q1 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 423,161$13,406,0007.47%
Aravt Global 2,300,000$72,864,0005.43%
Slate Path Capital LP 2,330,000$73,814,0005.16%
Orbimed Advisors 6,678,000$211,559,0002.02%
Iguana Healthcare Management, LLC 100,000$3,168,0001.53%
Iguana Healthcare Management, LLC 100,000$3,168,0001.53%
Penn Capital Management Company, LLC 709,045$22,463,0000.94%
HUSSMAN STRATEGIC ADVISORS, INC. 250,000$7,920,0000.79%
NEW AMSTERDAM PARTNERS LLC/NY 276,169$8,749,0000.76%
Matarin Capital Management, LLC 52,932$1,676,886,0000.74%
View complete list of IMPAX LABORATORIES INC shareholders